Neurologian yksikkö
Department of Neurology

Julkaisut 1989-1989
Publications 1989-1989

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Reinikainen KJ, Pitkänen A, Riekkinen PJ. 2'3'-cyclic nucleotide phosphodiesterase activity as an index of myelin in the post-mortem brains of patients with Alzheimer's disease. Neurosci Lett 1989:106:229-232.
2 Sirviö J, Riekkinen PJ, Hervonen A. Age-dependence of the solubility fractions of acetylcholinesterase in the cerebral cortex and cerebellum of the rat. Neurosci Lett 1989:96:218-222.
3 Helkala EL, Laulumaa V, Soikkeli R, Partanen J, Soininen H, Riekkinen PJ. Association of quantitative spectral analysis of EEG with neurophysiological functions in patients with dementia. Proceedings of the Symposium Aging of the Brain and Dementia: Ten Years Later, Florence 31.5-3.6.1989:139
4 Sirviö J, Pitkänen A, Pääkkönen A, Partanen J, Riekkinen PJ. Brain cholinergic enzymes and cortical EEG activity in young and old rats. Comp Biochem Physiol 1989:94C:277-283
5 Nousiainen U, Mervaala E, Uusitupa M, Ylinen A, Sivenius J. Cardiac arrhythmias in the differential diagnosis of epilepsy. J Neurol 1989:236:93-96.
6 Riekkinen PJ, Ylinen A, Halonen T, Sivenius J, Pitkänen A. Cerebrospinal fluid GABA and seizure control with vigabatrin. Br J Clin Pharmacol 1989:27:87-94.
7 Koponen H, Stenbäck U, Mattila E, Reinikainen K, Soininen H, Riekkinen P. Cerebrospinal fluid somatostatin in delirium. Psychol Med 1989:19:605-609.
8 Halonen T, Pitkänen A, Riekkinen PJ. Changes in amino acid levels in rat brain during chronic vigabatrin treatment. Proceedings of the Annual Meeting of the American Epilepsy Society Boston 3.-6.12.1989. Epilepsia 1989:30:648
9 Sirviö J. The cholinergic system in ageing and dementia with special reference to acetylcholinesterase. University of Kuopio. Series of Reports. Department of Neurology 12
10 Sirviö J, Kutvonen R, Soininen H, Hartikainen P, Riekkinen PJ. Cholinesterases in the cerebrospinal fluid, plasma and erythrocytes of patients with Alzheimer's disease. J Neural Transm 1989:75:119-127
11 Koponen H, Hurri L, Stenbäck U, Mattila E, Soininen H, Riekkinen PJ. Computed tomography findings in delirium. J Nerv Ment Dis 1989:177:226-231
12 Salmon DP, Riekkinen PJ, Katzman R, Zhang M, Jin H, Yu E. Cross-cultural studies of dementia. Arch Neurol 1989:46:769-772.
13 Koponen H, Stenbäck U, Mattila E, Reinikainen K, Soininen H, Riekkinen P. CSF beta-endorphin-like immunoreactivity in delirium. Biol Psychiatry 1989:25:938-944.
14 Koponen H, Stenbäck U, Mattila E, Soininen H, Reinikainen K, Riekkinen PJ. Delirium among elderly persons admitted to a psychiatric hospital: Clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand 1989:79:579-585.
15 Koponen H, Riekkinen PJ. Delirium in the elderly. A review. Psychiatr Fenn 1989:20:129-136.
16 Koponen H. Delirium in the elderly: A clinical, neurochemical, neuropsychological and neuroradiological study. University of Kuopio. Series of Reports. Department of Neurology 13
17 Helkala EL, Laulumaa V, Soininen H, Riekkinen PJ. Different error pattern of episodic and semantic memory in Alzheimer's disease and Parkinson's disease with dementia. Neuropsychologia 1989:27:1241-1248
18 Sirviö J, Rinne JO, Valjakka A, Rinne UK, Riekkinen PJ, Paljärvi L. Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease. J Neurol Sci 1989:90:23-32.
19 Kälviäinen R, Sivenius J, Ylinen A, Riekkinen PJ. A double blind study of gabapentin in treatment of partial seizures. Proceedings of the Annual Meeting of the American Epilepsy Society, Boston 3.-6.12.1989. Epilepsia 1989:30:661
20 Koponen H, Partanen J, Pääkkönen A, Mattila E, Riekkinen PJ. EEG spectral analysis in delirium. J Neurol Neurosurg Psychiatry 1989:52:980-985.
21 Halonen T, Saano V, Pitkänen A, Riekkinen PJ. Effect of administration of vigabatrin on GABA levels and on GABA/benzodiazepine receptor binding in rat brain. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 1989:3:12
22 Pitkänen A, Valjakka A, Pääkkönen A, Sirviö J, Jousmäki V, Partanen J, Riekkinen PJ. Effect of cysteamine on levels of somatostatin-like immunoreactivity and chatecholamines and on electroencephalogram in the rat brain. Neuropeptides 1989:14:1-9.
23 Pitkänen A, Hyttinen JM, Riekkinen PJ. Effect of cysteamine on somatostatin-like immunoreactivity in the amygdala-kindled rat brain. Neuropeptides 1989:14:11-16.
24 Pitkänen A, Matilainen R, Ruutiainen T, Luukkainen R, Mervaala E, Riekkinen P. Effect of vigabatrin on epilepsy in mentally retarted patients: a 2-year follow-up study. Proceedings of the American Academy of Neurology 41st Annual Meeting, Chicago 13.-19.4.1989. Neurology 1989:39:Suppl 1:297
25 Kälviäinen R, Äikiä M, Sivenius J, Saksa M, Riekkinen PJ. Effects of gamma-vinyl GABA monotherapy oncognitive functioning in patients with newly diagnosed epilepsy. Proceedings of the Annual Meeting of the American Epilepsy Society, Boston 3.-6.11.1989. Epilepsia 1989:30:639
26 Mervaala E, Partanen J, Nousiainen U, Sivenius J, Riekkinen P. Electrophysiologic effects of Gamma-Vinyl GABA and Carbamazepine. Epilepsia (NY) 1989:30:189-193.
27 Halonen T, Pitkänen A, Ylinen A, Riekkinen PJ. GABA levels in human and rat CSF during vigabatrin treatment. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 1989:3:12
28 Sivenius J. History of epilepsy treatment in Finland. History of neurology. Cogito 1989:1:21-23
29 Nousiainen U, Mervaala E, Ylinen A, Uusitupa M, Riekkinen P. The importance of the electrocardiogram in ambulatory electroencephalographic recordings. Arch Neurol 1989:46:1171-1174.
30 Keränen T, Sillanpää M, Riekkinen PJ. Incidence and prevalence of epilepsy in adults in Eastern Finland. Epilepsia (NY) 1989:30:413-421.
31 Pitkänen A, Matilainen R, Halonen T, Kutvonen R, Hartikainen P, Riekkinen P. Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients. J Neural Transm 1989:76:221-230
32 Pitkänen A, Hyttinen JM, Sirviö J, Jolkkonen J, Sarlund H, Riekkinen PJ. The levels of somatostatin in the brain and CSF of rat after carbamazepine administration. Pharmacol Toxicol 1989:64:266-271.
33 Soininen H, Partanen J, Laulumaa V, Helkala EL, Laakso M, Riekkinen PJ. Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1989:72:290-297.
34 Lepola U, Jolkkonen J, Rimon R, Riekkinen P. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder. Neuropsychobiology 1989:21:182-186.
35 Pitkänen A, Halonen T, Ylinen A, Matilainen R, Riekkinen P. Modulation of GABAergic transmission in the treatment of epilepsy. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 1989:1:16-21
36 Nousiainen U, Riekkinen P, Airaksinen E, eds. New trends in epilepsy and its treatment. Proceedings of the First Vaajasalo Epilepsy Symposium, Kuopio, May 18 and 19, 1989. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 1/1989
37 Reinikainen KJ, Riekkinen PJ. Noncholinergic neurotransmitter markers in the CSF of patients with dementia of Alzheimer type. Julkaisussa: Biological Markers in Dementia of Alzheimer Type, Proceedings book of the Symposium on Ageing Disorders, Stockholm 24.-25.1989. No 1
38 Sivenius J. Ohimenevän aivoiskemian ennuste ja hoito. Duodecim 1989:105:632-641.
39 Lepola U, Jolkkonen J, Riekkinen P. On biological aspects of panic disorders. Psychiatr Fenn Suppl 1989:24-28
40 Helkala EL, Laulumaa V, Soininen H, Riekkinen PJ. Recall and recognition memory in patients with Alzheimer's and Parkinson's disease. Parkinson/Alzheimer Digest 1989:1:15-16
41 Mervaala E, Partanen J, Nousiainen U, Riekkinen P. Somatosensory evoked potential dynamics in Baltic progressive myoclonus epilepsy. Electroencephalogr Clin Neurophysiol 1989:72:95.
42 Pitkänen A, Lepola U, Ylinen A, Riekkinen PJ. Somatostatin and beta-endorphin levels in cerebrospinal fluid of nonmedicated and medicated patients with epileptic seizures. Neuropeptides 1989:13:9-15.
43 Pitkänen A. Somatostatin in experimental and human epilepsy. University of Kuopio. Series of Reports. Department of Neurology 14
44 Pitkänen A, Beal MF, Sirviö J, Swartz KJ, Männistö PT, Riekkinen PJ. Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brain of pentylenetetrazol-kindled rats. Neuropeptides 1989:14:197-207.
45 Pitkänen A, Hyttinen JM, Ylinen A, Riekkinen PJ. Somatostatinergic system and amygdala-kindling: Effect of cysteamine administration. Proceedings of the Annual Meeting of the American Epilepsy Society, Boston 3.-6.12.1989. Epilepsia 1989:30:686-687
46 Koponen H, Reinikainen KJ, Jolkkonen J, Riekkinen PJ. Somatostatin-like immunoreactivity in the cerebrospinal fluid of chronic alcoholocs with cognitive impairment. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 1989:3:23
47 Riekkinen PJ, Pitkänen A, Ylinen A, Sivenius J, Halonen T. Specificity of Vigabatrin for the GABAergic system in human epilepsy. Epilepsia (NY) 1989:30:Suppl 3.
48 Jolkkonen J, Helkala EL, Kutvonen R, Lehtinen M, Riekkinen PJ. Vasopressin levels in CSF of Alzheimer patients: Correlations with monoamine metabolites and neuropsychological test performance. Psychoneuroendocrinology 1989:14:89-95
49 Nousiainen U, Mervaala E, Suomalainen T, Tuunainen A, Riekkinen P. Videotelemetry, ambulatory and routine EEG in intractable seizure disorders. Kuopion yliopiston julkaisuja. Lääketiede. Tilastot ja selvitykset 1989:1:168
50 Matilainen R, Pitkänen A, Ruutiainen T, Mervaala E, Riekkinen P. Vigabatrin in epilepsy in mentally retarted patients. Br J Clin Pharmacol 1989:27:113-118.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 24.1.2013 Publications Data Base 24.1.2013